Parkinsonism Provoked by Alcoholism
Ann Neurol 9:84-86, Carlen,P.L.,et al, 1981
Long-term Prognosis after Infantile Spasms:Statistical Study of Prognostic Factors
Develop Med Child Neurol 23:51-65, Marsumoto,A.,et al, 1981
Computed Tomography Brain Scanning In Alcohol Withdrawal Seizures
Ann Int Med 94:519-522, Feussner,J.R.,et al, 1981
Management of Alcohol Withdrawal Symptoms
Editorial, BMJ 282:5021981., , 1981
Is L-DOPA Drug Holiday Useful
Neurol 30:785-788, Direnfield,L.K.,et al, 1980
Drug Holiday & Management of Parkinson Disease
Neurol 30:1257-1261, Weiner,W.J.,et al, 1980
Status Epilepticus
Am J Med 69:657-665, Aminoff,M.J.,et al, 1980
Lorazepam Withdrawal Seizures
BMJ 280:1163-1164, Scobie,I.N.,et al, 1980
Drug Holidays for Patients with Parkinsonism
JAMA 242:17-21, Clark,W.A., 1979
Carbamazepine:Prevention of Alcohol Withdrawal Seizures
S. , Neurol 29:1397-1401979., Chu,N., 1979
Role of Magnesium Depletion in Wernicke-Korsakoff Syndrome
NEJM 298:743, Flink,E.B., 1978
Auditory Brain Stem Potentials in Chronic Alcohol Intoxication & Alcohol Withdrawal
Arch Neurol 35:596-602, Chu,N-S., 1978
Phenytoin & Methadone Tolerance
NEJM 294:227, Finelli,P.F., 1976
Alcohol Intoxication & Withdrawal
NEJM 294:757, Sellers,E.M.,et al, 1976
Rifampin Induced Methadone Withdrawal
NEJM 294:1104, Kreek,M.J.,et al, 1976
Microsomal Enzume Induction by Methadone & its Implications on Toler. to Methad. Tox
Nature 253:200, Masten,L.W.,et al, 1975
Benzodiazepines
NEJM 29l:l0ll, Nov 1974:29l:l239., Greenblatt,D.J.,et al, 1974
Prognosis in Childhood Epilepsy
NEJM 286:169, Olowach,J.,et al, 1972
Axioms on Alcohol Withdrawal
Hosp Med 1970 Feb., Miller,B.H., 1970
Restless Legs
Lead Article BMJ 758, Dec1970., , 1970
Long-Term Follow-up of Patients with Petit Mal
Arch Neurol 16:595, Charlton,M.H.,et al, 1967
A Study of Epilepsy in the Alcoholic Patient
Modern Neurology, Chap 42 p. 555., Victor,M., 1850
Alcoholism
Clin Neurol Chap 22 p. 1084, A. B. Baker Text Book of Neurology., Victor,M., 1850
A 41-Year-Old Man with Steroid-Responsive Hemiparesis
Neurol 106:e214088, Obaidi,Z.A.,et al, 2026
Reversible Leukoencephalopathy and Parkinsonism Due to CNS Involvement in Cryoglobulinemia
Neurol 106:e214622, German,A.,et al, 2026
Progressive Quadriparesis and Falls in a 66-Year-Old Man With Longstanding Human Immunodeficiency Virus
Neurol 106:e214621, Ong,B.A. & Carlson,A.K., 2026
Peripheral Neuropathy, A Review
JAMA 335:255-266, Mauermann,M.L. & Staff,N.P., 2026
Calcitonin Gene-Related Peptide-Targeted Therapy in Migraine: Current Role and Future Perspectives
Lancet 405:1014-1026, Versijpt,J.,et al, 2025
Severe Myotonic Crisis Resembling Malignant Hyperthermia
Neurol 104:e213497, Wadhwani,A.R.,et al, 2025
Inebilizumab for Treatment of IgG4-Related Disease
NEJM 392:1168-1177, Stone,J.H.,et al, 2025
Beyond Glucocorticoids for IgG4-Related Disease
NEJM 392:1232-1233, Spiera,R., 2025
Alteplase for Posterior Circulation Ischemic Stropke at 4.5 to 24 Hours
NEJM 392:1288-1296, Yan,S.,et al, 2025
Left Atrial Appendage Closure After Ablation for Atrial Fibrillation
NEJM 392:1277-1287, Wazni,O.M.,et al, 2025
"Innumerable" lesion burden on brain MRI - a diagnostic approach
Diagnosis doi.org/10.1515/dx- 2025-2029, Finelli,P.F., 2025
Chronic Neuropsychiatric Sequelae Associated with Kambo Intoxication
JAMA Neurol 82:418-419, Jauregui,R.,et al, 2025
Long-Term Effects of Antidarsagene Autotemcel for Metachromatic Leukodystrophy
NEJM 392:1609-1620, Fumagalli,F.,et al, 2025
Anticoagulation or Antiplatelet Therapy for Device-Detected Atrial Fibrillation
NEJM 392:1749-1751, Gorey,S., 2025
Postprocedural Brachial Neuritis:Clinical, Electrodiagnostic, and Neuroimaging Features
AJNR 46:1050-1055, Ambati,V.S.,et al, 2025
Validation of an Artificial Intelligence-Powered Virtual Assistant for Emergency Triage in Neurology
Neurologist 30:155-163, Alessandro,L.,et al, 2025
Progress Toward Mitigating Disability Progression in Multiple Sclerosis
NEJM 392:1966-1968, Calabresi,P.A., 2025
General AI May Revolutionize Neurology 0 Or It Might be Bad
JAMA Neurol doi 10.1001/JAMANEUROL.2025.0905, Westover,M.B. & Westover,A.M., 2025
Upadacitinib - An Up-and-Comer for Treatment of Giant-Cell Arteritis
NEJM 392:2062-2064, Koster,M.J. & Warrington,K.J., 2025
Comprehensive Analysis of Neurologic Complications following Transradial Cerebral Angiography
AJNR 46:1166-1172, Kim,H.,et al, 2025
A 69-Year-Old Woman with Ophthalmoplegia
Neurol 104:e213763, Yu, H & Frey, J, 2025
Risk of Dementia in Individuals with Emergency Department Visits or Hospitalizations Due to Cannabis
JAMA Neurol 82:570-579, Myran,D.T.,et al, 2025
Spectrum of Intracranial Hemorrhages in Cerebral Venous Thrombosis, A Pictorial Case Series and Review of Pathophysiology and Management
Neurologist 30:45-51, Jha,S.,et al, 2025
Efficacy and Safety of IV Thrombolysis for Acute Ischemic Stroke Patients with Moyamoya Disease
Neurol 104:e210243, Chen,H.,et al, 2025
Amyloid-Related Imaging Abnormalities (ARIA) in Clinical Trials of Gantenerumab in Early Alzheimer Disease
JAMA Neurol 92:19-29, Salloway,S.,et al, 2025
Stroke-Like Migraine Attacks After Radiation Therapy Syndrome
Neurol 104:e210203, Lubotzky,A.,t al, 2025
FUTURE-AI: International Consensus Guideline for Trustworthy and Deployable Artificial Intelligence in Healthcare
BMJ 388:e081554, Lekadir,K.,et al, 2025